- Home
- HLF vs NKTR Comparison
HLF vs NKTR Comparison
Compare HLF & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HLF | NKTR |
|---|---|---|
| Founded | 1980 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 2004 | 1996 |
Fundamental Metrics
Financial Performance| Metric | HLF | NKTR |
|---|---|---|
| Price | $13.80 | $76.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $18.67 | ★ $130.00 |
| AVG Volume (30 Days) | ★ 1.1M | 782.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.20 | N/A |
| Revenue | ★ $5,037,500,000.00 | $307,711,000.00 |
| Revenue This Year | $4.91 | N/A |
| Revenue Next Year | $3.90 | N/A |
| P/E Ratio | $6.55 | ★ N/A |
| Revenue Growth | 0.89 | ★ 86.00 |
| 52 Week Low | $6.20 | $0.43 |
| 52 Week High | $20.40 | $78.81 |
Technical Indicators
Market Signals| Indicator | HLF | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 34.23 | 60.83 |
| Support Level | $12.55 | $52.99 |
| Resistance Level | $15.17 | N/A |
| Average True Range (ATR) | 0.55 | 4.69 |
| MACD | -0.07 | -0.44 |
| Stochastic Oscillator | 10.53 | 85.53 |
Price Performance
Historical ComparisonAbout HLF Herbalife Ltd.
Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.